Table 3. Receipt of Corticosteroids Among Patients in ISARIC Data Set With Severe or Critical COVID-19 Disease, by Time Period and World Health Organization Geographic Region.

Period	Patients, No. (%) [Bonferroni-corrected 95% CI]
	Global	Africa	Americas	Eastern Mediterranean	Europe	South-East Asia	Western Pacific
January 31 to May 31, 2020	16 312 of 63 017 (25.9) [25.3-26.4]	119 of 2363 (5.0) [3.7-6.4]	2098 of 5970 (35.1) [33.2-37.0]	501 of 999 (50.2) [45.3-55.0]	13 321 of 52 650 (25.3) [24.7-25.9]	67 of 242 (27.7) [18.8-36.5]	206 of 793 (26.0) [21.2-30.8]
June 1 to August 31, 2020	11 791 of 43 764 (26.9) [26.3-27.6]	5495 of 33 975 (16.2) [15.6-16.8]	1528 of 2102 (72.7) [69.7-75.7]	1149 of 1912 (60.1) [56.6-63.5]	2675 of 4458 (60.0) [57.7-62.3]	735 of 1076 (68.3) [63.9-72.7]	209 of 241 (86.7) [80.0-93.5]
September 1, 2020, to September 1, 2022	146 204 of 328 070 (44.6) [44.3-44.8]	31 588 of 185 191 (17.1) [16.8-17.3]	5421 of 6095 (88.9) [87.7-90.2]	4447 of 6434 (69.1) [67.3-70.9]	99 434 of 123 077 (80.8) [80.4-81.1]	4895 of 6715 (72.9) [71.2-74.6]	419 of 558 (75.1) [69.5-80.7]

Abbreviation: ISARIC, International Severe Acute Respiratory and Emerging Infections Consortium.